Literature DB >> 18544739

The rise of raloxifene and the fall of invasive breast cancer.

V Craig Jordan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544739     DOI: 10.1093/jnci/djn177

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations.

Authors:  Ping Fan; V Craig Jordan
Journal:  Steroids       Date:  2014-06-12       Impact factor: 2.668

Review 2.  Raloxifene: a review of its use in the prevention of invasive breast cancer.

Authors:  Marit D Moen; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis.

Authors:  V Craig Jordan; Joan S Lewis-Wambi; Roshani R Patel; Helen Kim; Eric A Ariazi
Journal:  Breast       Date:  2009-10       Impact factor: 4.380

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.